BHVN Insider Trading

Insider Ownership Percentage: 12.40%
Insider Buying (Last 12 Months): $6,239,870.00
Insider Selling (Last 12 Months): $16,498,698.66

Biohaven Pharmaceutical Insider Trading History Chart

This chart shows the insider buying and selling history at Biohaven Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Biohaven Pharmaceutical Share Price & Price History

Current Price: $152.40
Price Change: Price Increase of +0.2 (0.13%)
As of 09/28/2022 12:51 PM ET

This chart shows the closing price history over time for BHVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Biohaven Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/19/2022Gregory H. BaileyDirectorBuy38,000$148.04$5,625,520.002,583,658View SEC Filing Icon  
5/10/2022George C. ClarkCAOSell4,200$141.50$594,300.004,065View SEC Filing Icon  
1/19/2022George C. ClarkCAOSell9,375$117.01$1,096,968.75View SEC Filing Icon  
12/20/2021George C. ClarkCAOSell1,915$123.84$237,153.60View SEC Filing Icon  
12/20/2021Julia P. GregoryDirectorSell12,000$125.00$1,500,000.00View SEC Filing Icon  
12/15/2021Elyse StockInsiderSell21,919$105.49$2,312,235.31View SEC Filing Icon  
12/10/2021James EngelhartCFOSell35,000$102.55$3,589,250.00View SEC Filing Icon  
11/29/2021Declan DooganDirectorSell24,525$112.80$2,766,420.00View SEC Filing Icon  
11/16/2021Declan DooganDirectorSell37,740$116.65$4,402,371.00View SEC Filing Icon  
11/10/2021John W. ChildsDirectorBuy5,000$122.87$614,350.00View SEC Filing Icon  
3/17/2021John W. ChildsDirectorBuy13,157$76.00$999,932.00
3/2/2021John W. ChildsDirectorBuy10,000$85.14$851,400.002,532,644View SEC Filing Icon  
11/23/2020John W. ChildsDirectorBuy5,000$89.55$447,750.002,516,938View SEC Filing Icon  
11/2/2020William A. Jones, Jr.InsiderSell30,000$76.22$2,286,600.0031,755View SEC Filing Icon  
10/22/2020Gregory H. BaileyDirectorSell24,566$79.47$1,952,260.022,559,161View SEC Filing Icon  
10/19/2020Gregory H. BaileyDirectorSell4,554$78.98$359,674.922,585,181View SEC Filing Icon  
10/16/2020Gregory H. BaileyDirectorSell3,748$78.88$295,642.242,585,181View SEC Filing Icon  
10/12/2020Gregory H. BaileyDirectorSell6,729$78.87$530,716.232,588,929View SEC Filing Icon  
10/8/2020Kimberly GentileSVPSell23,500$76.34$1,793,990.0027,139View SEC Filing Icon  
9/21/2020John W. ChildsDirectorBuy3,322$59.25$196,828.502,511,938View SEC Filing Icon  
9/11/2020John W. ChildsDirectorBuy6,678$59.00$394,002.002,508,616View SEC Filing Icon  
7/8/2020Gregory H. BaileyDirectorSell50,000$75.22$3,761,000.002,601,649View SEC Filing Icon  
7/8/2020Robert BermanInsiderSell58,404$75.25$4,394,901.0058,745View SEC Filing Icon  
6/24/2020Gregory H. BaileyDirectorSell3,995$69.86$279,090.702,737,829View SEC Filing Icon  
6/23/2020Robert BermanInsiderSell4,296$75.05$322,414.804,637View SEC Filing Icon  
6/22/2020Gregory H. BaileyDirectorSell80,331$73.24$5,883,442.442,973,646View SEC Filing Icon  
6/19/2020Gregory H. BaileyDirectorSell164,031$71.22$11,682,287.822,973,646View SEC Filing Icon  
6/18/2020Robert BermanInsiderSell61,314$75.27$4,615,104.7836,655View SEC Filing Icon  
6/17/2020Kimberly GentileSVPSell24,000$70.20$1,684,800.0027,639View SEC Filing Icon  
6/15/2020Declan DooganDirectorSell80,000$66.73$5,338,400.00373,913View SEC Filing Icon  
6/12/2020Declan DooganDirectorSell160,000$66.00$10,560,000.00373,913View SEC Filing Icon  
6/12/2020Elyse StockInsiderSell36,966$66.00$2,439,756.0022,560View SEC Filing Icon  
6/11/2020James EngelhartCFOSell73,725$66.00$4,865,850.0015,975View SEC Filing Icon  
6/10/2020John TiltonInsiderSell52,000$67.38$3,503,760.0052,770View SEC Filing Icon  
6/8/2020Kimberly GentileSVPSell600$70.05$42,030.004,239View SEC Filing Icon  
4/6/2020John W. ChildsDirectorSell150,000$31.25$4,687,500.002,682,279View SEC Filing Icon  
1/22/2020Eric AguiarDirectorSell2,021$56.48$114,146.08View SEC Filing Icon  
1/9/2020Eric AguiarDirectorSell30,000$56.39$1,691,700.0030,000View SEC Filing Icon  
12/30/2019Robert BermanInsiderSell125,000$53.22$6,652,500.00125,341View SEC Filing Icon  
12/16/2019Eric AguiarDirectorSell3,537$55.13$194,994.81View SEC Filing Icon  
12/9/2019Eric AguiarDirectorSell4,072$55.11$224,407.92View SEC Filing Icon  
11/22/2019Eric AguiarDirectorSell1,250$55.24$69,050.0012,000View SEC Filing Icon  
11/20/2019Eric AguiarDirectorSell6,729$52.20$351,253.80View SEC Filing Icon  
11/20/2019Kimberly GentileSVPSell3,935$53.03$208,673.053,935View SEC Filing Icon  
10/18/2019Elyse StockInsiderSell17,700$45.07$797,739.0017,700View SEC Filing Icon  
10/15/2019Elyse StockInsiderSell800$45.01$36,008.00800View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Biohaven Pharmaceutical (NYSE:BHVN)

78.19% of Biohaven Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BHVN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Biohaven Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/13/2022Brown Advisory Inc.746,074$108.71M0.2%-12.6%1.043%Search for SEC Filing on Google Icon
8/30/2022Verition Fund Management LLC86,490$12.60M0.2%+3,509.8%0.121%Search for SEC Filing on Google Icon
8/24/2022Prelude Capital Management LLC51,361$7.48M0.2%N/A0.072%Search for SEC Filing on Google Icon
8/22/2022Legal & General Group Plc87,333$12.73M0.0%+58.7%0.122%Search for SEC Filing on Google Icon
8/22/2022ExodusPoint Capital Management LP2,466$0.36M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/19/2022Walleye Capital LLC21,354$3.11M0.1%-12.8%0.030%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.718,679$104.72M0.0%+92.7%1.005%Search for SEC Filing on Google Icon
8/17/2022Nomura Holdings Inc.2,340$0.33M0.0%+134.0%0.003%Search for SEC Filing on Google Icon
8/17/2022Parallax Volatility Advisers L.P.20,004$2.91M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/16/2022First Republic Investment Management Inc.8,116$1.18M0.0%-57.9%0.011%Search for SEC Filing on Google Icon
8/16/2022Woodline Partners LP123,502$18M0.3%N/A0.173%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD521,580$76M0.0%+1.1%0.729%Search for SEC Filing on Google Icon
8/16/2022Prudential Financial Inc.5,406$0.79M0.0%-3.1%0.008%Search for SEC Filing on Google Icon
8/16/2022Pentwater Capital Management LP1,430,000$208.37M2.4%N/A2.000%Search for SEC Filing on Google Icon
8/16/2022DAFNA Capital Management LLC110,100$16.04M4.4%+41.9%0.154%Search for SEC Filing on Google Icon
8/16/2022Driehaus Capital Management LLC50,830$7.41M0.1%N/A0.071%Search for SEC Filing on Google Icon
8/15/2022AQR Capital Management LLC18,737$2.73M0.0%-11.1%0.026%Search for SEC Filing on Google Icon
8/15/2022TIG Advisors LLC1,029,868$150.06M6.2%N/A1.440%Search for SEC Filing on Google Icon
8/15/2022State Street Corp1,745,046$254.27M0.0%+5.4%2.441%Search for SEC Filing on Google Icon
8/15/2022Macquarie Group Ltd.62,875$9.16M0.0%-91.6%0.088%Search for SEC Filing on Google Icon
8/15/2022Parallax Volatility Advisers L.P.20,004$2.91M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/15/2022Westchester Capital Management LLC242,790$35.38M1.0%N/A0.340%Search for SEC Filing on Google Icon
8/15/2022Point72 Hong Kong Ltd1,622$0.24M0.0%-4.0%0.002%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC5,154$0.75M0.0%-62.1%0.007%Search for SEC Filing on Google Icon
8/15/2022Sio Capital Management LLC35,000$5.10M1.9%N/A0.049%Search for SEC Filing on Google Icon
8/15/2022Voya Investment Management LLC23,559$3.43M0.0%-66.5%0.033%Search for SEC Filing on Google Icon
8/15/2022Sei Investments Co.54,531$7.95M0.0%+214.7%0.076%Search for SEC Filing on Google Icon
8/15/2022Natixis Advisors L.P.13,251$1.93M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/15/2022Soros Fund Management LLC1,255,001$182.87M3.3%N/A1.755%Search for SEC Filing on Google Icon
8/15/2022UBS Asset Management Americas Inc.338,714$49.35M0.0%+458.8%0.474%Search for SEC Filing on Google Icon
8/13/2022Ramius Advisors LLC20,900$3.05M1.5%N/A0.029%Search for SEC Filing on Google Icon
8/13/2022Teacher Retirement System of Texas9,355$1.36M0.0%-23.3%0.013%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC1,420$0.21M0.0%N/A0.002%Search for SEC Filing on Google Icon
8/13/2022Zurcher Kantonalbank Zurich Cantonalbank 7,321$1.07M0.0%-7.4%0.010%Search for SEC Filing on Google Icon
8/13/2022Gamco Investors INC. ET AL20,212$2.95M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC70,400$10.26M0.0%N/A0.098%Search for SEC Filing on Google Icon
8/13/2022Vanguard Personalized Indexing Management LLC6,327$0.92M0.0%+87.2%0.009%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.29,157$4.25M0.0%+5.4%0.041%Search for SEC Filing on Google Icon
8/12/2022Allianz Asset Management GmbH235,068$34.25M0.0%+225.4%0.329%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp574,770$83.75M0.0%+9.2%0.804%Search for SEC Filing on Google Icon
8/12/2022Ensign Peak Advisors Inc102,726$14.97M0.0%-24.9%0.144%Search for SEC Filing on Google Icon
8/12/2022Bardin Hill Management Partners LP141,207$20.58M5.4%N/A0.198%Search for SEC Filing on Google Icon
8/12/2022Hudson Bay Capital Management LP176,489$25.72M0.2%N/A0.247%Search for SEC Filing on Google Icon
8/12/2022Credit Suisse AG53,423$7.79M0.0%-3.7%0.075%Search for SEC Filing on Google Icon
8/12/2022DLD Asset Management LP25,000$3.64M0.3%N/A0.035%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC26,479$3.86M0.0%-41.2%0.037%Search for SEC Filing on Google Icon
8/12/2022Berry Street Capital Management LLP172,500$25.14M3.1%N/A0.241%Search for SEC Filing on Google Icon
8/12/2022FMR LLC117,508$17.12M0.0%-92.4%0.164%Search for SEC Filing on Google Icon
8/12/2022Public Sector Pension Investment Board180,000$26.23M0.2%N/A0.252%Search for SEC Filing on Google Icon
8/12/2022BNP Paribas Arbitrage SA13,884$2.02M0.0%+146.1%0.019%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers79,483$11.58M0.0%+27.2%0.111%Search for SEC Filing on Google Icon
8/11/2022Cetera Advisor Networks LLC3,030$0.44M0.0%+8.1%0.004%Search for SEC Filing on Google Icon
8/11/2022Bridgewater Associates LP6,308$0.92M0.0%+6.9%0.009%Search for SEC Filing on Google Icon
8/11/2022O Shaughnessy Asset Management LLC2,286$0.33M0.0%+13.3%0.003%Search for SEC Filing on Google Icon
8/11/2022Clearbridge Investments LLC830,776$121.05M0.1%-27.9%1.162%Search for SEC Filing on Google Icon
8/11/2022Trexquant Investment LP3,504$0.51M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/11/2022Deutsche Bank AG98,932$14.42M0.0%-87.2%0.138%Search for SEC Filing on Google Icon
8/11/2022Sigma Planning Corp2,502$0.37M0.0%-61.4%0.003%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG274,026$39.93M0.0%+628.2%0.383%Search for SEC Filing on Google Icon
8/11/2022Yakira Capital Management Inc.55,550$8.09M1.3%N/A0.078%Search for SEC Filing on Google Icon
8/11/2022Bank of Montreal Can44,967$6.51M0.0%N/A0.063%Search for SEC Filing on Google Icon
8/11/2022Knott David M Jr25,051$3.65M1.5%+219.1%0.035%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.876,584$127.73M0.0%-36.0%1.226%Search for SEC Filing on Google Icon
8/10/2022Mutual of America Capital Management LLC34,866$5.08M0.1%-0.7%0.049%Search for SEC Filing on Google Icon
8/10/2022Mackenzie Financial Corp4,253$0.62M0.0%-81.6%0.006%Search for SEC Filing on Google Icon
8/10/2022Industrial Alliance Investment Management Inc.35,770$5.21M0.1%-1.0%0.051%Search for SEC Filing on Google Icon
8/10/2022California Public Employees Retirement System116,708$17.01M0.0%-0.6%0.165%Search for SEC Filing on Google Icon
8/10/2022Principal Financial Group Inc.20,810$3.03M0.0%-18.6%0.030%Search for SEC Filing on Google Icon
8/10/2022Inspire Investing LLC1,453$0.21M0.0%-26.5%0.002%Search for SEC Filing on Google Icon
8/9/2022Swiss National Bank141,300$20.59M0.0%+1.4%0.200%Search for SEC Filing on Google Icon
8/9/2022Pictet Asset Management SA219,848$32.03M0.0%-56.8%0.312%Search for SEC Filing on Google Icon
8/9/2022SeaCrest Wealth Management LLC1,825$0.27M0.0%-34.8%0.003%Search for SEC Filing on Google Icon
8/9/2022Lazard Asset Management LLC1,243$0.18M0.0%+42.1%0.002%Search for SEC Filing on Google Icon
8/9/2022Alpine Associates Management Inc.533,800$77.78M2.9%N/A0.757%Search for SEC Filing on Google Icon
8/8/2022Keebeck Alpha LP20,562$3M1.3%N/A0.029%Search for SEC Filing on Google Icon
8/8/2022AdvisorShares Investments LLC2,288$0.33M0.1%N/A0.003%Search for SEC Filing on Google Icon
8/8/2022Advisors Asset Management Inc.8,672$1.26M0.0%-63.3%0.012%Search for SEC Filing on Google Icon
8/8/2022Walleye Capital LLC21,354$3.11M0.1%-12.8%0.030%Search for SEC Filing on Google Icon
8/8/2022BCK Capital Management LP9,231$1.35M1.0%N/A0.013%Search for SEC Filing on Google Icon
8/8/2022Oppenheimer Asset Management Inc.7,644$1.11M0.0%-3.9%0.011%Search for SEC Filing on Google Icon
8/8/2022Rice Hall James & Associates LLC263,030$38.33M1.9%-5.0%0.373%Search for SEC Filing on Google Icon
8/8/2022Bank of Nova Scotia4,877$0.71M0.0%-8.0%0.007%Search for SEC Filing on Google Icon
8/8/2022OneAscent Wealth Management LLC1,524$0.22M0.1%N/A0.002%Search for SEC Filing on Google Icon
8/8/2022Curi Wealth Management LLC1,725$0.25M0.0%N/A0.002%Search for SEC Filing on Google Icon
8/8/2022Compass Financial Advisors LLC2,653$0.39M0.5%-18.4%0.004%Search for SEC Filing on Google Icon
8/8/2022Meeder Asset Management Inc.408$59K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/5/2022State Board of Administration of Florida Retirement System19,293$2.81M0.0%+7.8%0.027%Search for SEC Filing on Google Icon
8/5/2022Mint Tower Capital Management B.V.9,218$1.34M0.1%N/A0.013%Search for SEC Filing on Google Icon
8/5/2022Illinois Municipal Retirement Fund4,887$0.71M0.0%N/A0.007%Search for SEC Filing on Google Icon
8/5/2022Los Angeles Capital Management LLC4,911$0.72M0.0%-25.7%0.007%Search for SEC Filing on Google Icon
8/4/2022Carret Asset Management LLC1,683$0.25M0.0%N/A0.002%Search for SEC Filing on Google Icon
8/3/2022Envestnet Asset Management Inc.33,204$4.84M0.0%+11.2%0.047%Search for SEC Filing on Google Icon
8/3/2022Nisa Investment Advisors LLC4,392$0.64M0.0%+18.6%0.006%Search for SEC Filing on Google Icon
8/3/2022Janney Montgomery Scott LLC3,421$0.50M0.0%+76.6%0.005%Search for SEC Filing on Google Icon
8/3/2022Wolverine Asset Management LLC10,465$1.52M0.0%N/A0.015%Search for SEC Filing on Google Icon
8/3/2022Candriam S.C.A.144,428$21.04M0.2%N/A0.205%Search for SEC Filing on Google Icon
8/3/2022Handelsbanken Fonder AB64,600$9.41M0.1%-76.8%0.092%Search for SEC Filing on Google Icon
8/2/2022Pinnacle Wealth Management Group Inc.1,600$0.23M0.2%N/A0.002%Search for SEC Filing on Google Icon
8/2/2022KRS Capital Management LLC3,815$0.56M0.8%-34.4%0.005%Search for SEC Filing on Google Icon
8/2/2022Banque Cantonale Vaudoise294$43K0.0%-32.7%0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Biohaven Pharmaceutical logo
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 for neuropsychiatric indications; and Verdiperstat, a product for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.
Read More on Biohaven Pharmaceutical

Today's Range

Now: $152.40
Low: $152.15
High: $152.43

50 Day Range

MA: $148.70
Low: $145.95
High: $152.20

52 Week Range

Now: $152.40
Low: $79.01
High: $152.56

Volume

16,458 shs

Average Volume

920,215 shs

Market Capitalization

$10.92 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Biohaven Pharmaceutical?

Biohaven Pharmaceutical's top insider shareholders include:
  1. Gregory Bailey (Director)
  2. John W Childs (Director)
  3. William A Jones Jr (Insider)
  4. Kimberly Gentile (SVP)
  5. George C Clark (CAO)
  6. Declan Doogan (Director)
  7. Elyse Stock (Insider)
  8. James Engelhart (CFO)
  9. Julia P Gregory (Director)
Learn More about top insider investors at Biohaven Pharmaceutical.

Who are the major institutional investors of Biohaven Pharmaceutical?

Biohaven Pharmaceutical's top institutional shareholders include:
  1. State Street Corp — 2.44%
  2. Pentwater Capital Management LP — 2.00%
  3. Soros Fund Management LLC — 1.76%
  4. TIG Advisors LLC — 1.44%
  5. Allspring Global Investments Holdings LLC — 1.29%
  6. JPMorgan Chase & Co. — 1.23%
Learn More about top institutional investors of Biohaven Pharmaceutical stock.

Which major investors are selling Biohaven Pharmaceutical stock?

During the last quarter, BHVN stock was sold by these institutional investors:
  1. FMR LLC
  2. Allspring Global Investments Holdings LLC
  3. Macquarie Group Ltd.
  4. Deutsche Bank AG
  5. JPMorgan Chase & Co.
  6. ARS Investment Partners LLC
  7. Clearbridge Investments LLC
  8. Pictet Asset Management SA
In the last year, company insiders that have sold Biohaven Pharmaceutical company stock include:
  1. Gregory Bailey (Director)
  2. John W Childs (Director)
  3. William A Jones Jr (Insider)
  4. Kimberly Gentile (SVP)
  5. George C Clark (CAO)
Learn More investors selling Biohaven Pharmaceutical stock.

Which major investors are buying Biohaven Pharmaceutical stock?

Within the previous quarter, BHVN stock was acquired by institutional investors including:
  1. Pentwater Capital Management LP
  2. Soros Fund Management LLC
  3. TIG Advisors LLC
  4. Versor Investments LP
  5. Alpine Associates Management Inc.
  6. Goldman Sachs Group Inc.
  7. UBS Asset Management Americas Inc.
  8. Westchester Capital Management LLC
During the last year, these company insiders have bought Biohaven Pharmaceutical stock:
  1. Gregory Bailey (Director)
  2. John W Childs (Director)
Learn More investors buying Biohaven Pharmaceutical stock.